Concepedia

Brendan Colgan

BC

3

Publications

118

Citations

3

H-Index

1989

Active since

Affiliations

Celerion (United Kingdom)(Current)

Respiratory Research Institute

Manchester University NHS Foundation Trust

German Center for Lung Research

Medicines Evaluation Unit

Brendan Colgan is an author at Celerion (United Kingdom) specializing in pharmacotherapy, clinical efficacy, and pharmacokinetics.

Top concepts

Publications per year

1989–2020

3

Publications

3

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

Dave Singh, Kai Michael Beeh, Brendan Colgan et al. · Respiratory Research · 2019 · 75 citations · Full text

Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis

Mirco Govoni, Michele Bassi, Stefano Vezzoli et al. · Respiratory Research · 2020 · 30 citations · Full text

Pharmacokinetic properties and clinical efficacy of once-daily sustained-release naproxen

J.G. Kelly, CD Kinney, John Devane et al. · European Journal of Clinical Pharmacology · 1989 · 13 citations

, , +3

Rows per page

1–3 of 3